🇺🇸 FDA
Patent

US 12391658

Sulfoxide and sulfone glucokinase activators and methods of use thereof

granted A61PA61P3/00

Quick answer

US patent 12391658 (Sulfoxide and sulfone glucokinase activators and methods of use thereof) held by VTV THERAPEUTICS LLC expires Mon Aug 14 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
VTV THERAPEUTICS LLC
Grant date
Tue Aug 19 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 14 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61P, A61P3/00